About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00203177

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Study to look at the effectiveness, tolerability and safety of two doses of Rasagiline (0.5 mg and 1mg) in advanced Parkinson's Disease (PD) Patients who have been treated with Levodopa/Carbidopa ther...

Lead sponsor: Teva Branded Pharmaceutical Products R&D, Inc.•7 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients must have completed the Week 26 visit of TVP 1012/133 (Visit 06) in accordance with the protocol.
•Women must be postmenopausal, surgically sterile, or using adequate birth control methods. Women of childbearing potential must have a negative pregnancy test at Baseline/Month 0.
•Patients must be willing and able to give informed consent.

Exclusion Criteria

•Serious or severe, test drug-related (probable or definite) adverse reaction in study TVP 1012/133.
•Premature discontinuation from study TVP 1012/133 for any reason.
•A clinically significant or unstable medical or surgical condition which would preclude safe and complete study participation. Such conditions may include cardiovascular, pulmonary hepatic, renal, metabolic diseases or malignancies as determined by medical history, physical exam, skin evaluation, laboratory tests, chest x-ray, or ECG.

Related studies

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

NCT07398157 · PD - Parkinson's Disease

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

NCT07330258 · Parkinson's Disease

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

NCT06508801 · Parkinson's Disease and Parkinsonism

RECRUITINGPhase 4

Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease

NCT07384429 · Parkinson's Disease, Insomnia, and more

RECRUITINGPhase 1

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264 · Healthy Volunteers (HV), Parkinson's Disease (PD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 9, 2010Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment254

Start dateOct 2001

Last updatedMar 9, 2010

Condition

Parkinson's Disease

Locations shown

Margolin Brain Institute

Fresno, California

Emory University

Atlanta, Georgia

Rush - Presbyterian St. Luke's Medical Center

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2010Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions